New Clinical Trials Offer Hope In The Fight Against Ebola In The Democratic Republic Of Congo

Multiple new clinical trials are underway to evaluate if various treatments will prove effective against the Bundibugyo Ebola ...

Octapharma USA Announces Expanded FDA Approval of wilate® for von Willebrand Disease Prophylaxis in Children Younger Than 6 Years

Octapharma USA announced that pediatric patients, including children younger than 6 years of age, with von Willebrand Disease (VWD) now have access to routine prophylaxis to help reduce the frequency ...
Healio

FDA expands Wilate approval to children younger than 6 years with von Willebrand disease

Wilate is now approved for routine prophylaxis across all patient ages and forms of von Willebrand disease. Trial results ...
MPR

FDA Expands Wilate Approval for VWD Prophylaxis in Children Under 6

Label expansion establishes the therapy as the first VWF concentrate indicated for routine prophylaxis across all age groups ...
ascopubs.org

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003

Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial This randomized phase II/III trial enrolled patients with SCLC, no brain ...